OTHER · Unmapped registry intervention
No intervention due to observational methods of study
Find medicine records ·
Find other trials using this name
Clinical trial
Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.
NCT04595734
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedLiver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancer Stage IVunresolved
Hepatitisverified · MONDO: hepatitis
Interventions
Sponsors & collaborators
Western Sydney Local Health Districtlead sponsor
University of Western Sydneycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04595734 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.